These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6088597)

  • 21. Binding of epsilon-toxin from Clostridium perfringens in the nervous system.
    Dorca-Arévalo J; Soler-Jover A; Gibert M; Popoff MR; Martín-Satué M; Blasi J
    Vet Microbiol; 2008 Sep; 131(1-2):14-25. PubMed ID: 18406080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurological disorders produced by Clostridium perfringens type D epsilon toxin.
    Finnie JW
    Anaerobe; 2004 Apr; 10(2):145-50. PubMed ID: 16701511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxin-induced vasogenic cerebral oedema in a rat model.
    Ghabriel MN; Zhu C; Reilly PL; Blumbergs PC; Manavis J; Finnie JW
    Acta Neurochir Suppl; 2000; 76():231-6. PubMed ID: 11450014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clostridium perfringens epsilon toxin induces permanent neuronal degeneration and behavioral changes.
    Morris WE; Goldstein J; Redondo LM; Cangelosi A; Geoghegan P; Brocco M; Loidl FC; Fernandez-Miyakawa ME
    Toxicon; 2017 May; 130():19-28. PubMed ID: 28237716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuronal damage produced in rat brains by Clostridium perfringens type D epsilon toxin.
    Finnie JW; Blumbergs PC; Manavis J
    J Comp Pathol; 1999 May; 120(4):415-20. PubMed ID: 10208737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An immunohistochemical study of plasma albumin extravasation in the brain of mice after the administration of Clostridium perfringens type D epsilon toxin.
    Finnie JW; Hajduk P
    Aust Vet J; 1992 Oct; 69(10):261-2. PubMed ID: 1445075
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of enzyme-linked immunosorbent assay for diagnosis of Clostridium perfringens enterotoxemias.
    el Idrissi AH; Ward GE
    Vet Microbiol; 1992 Jun; 31(4):389-96. PubMed ID: 1496812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain lesions associated with clostridium perfringens type D epsilon toxin in a Holstein heifer calf.
    Mete A; Garcia J; Ortega J; Lane M; Scholes S; Uzal FA
    Vet Pathol; 2013 Sep; 50(5):765-8. PubMed ID: 23381925
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Mander KA; Uzal FA; Williams R; Finnie JW
    J Vet Diagn Invest; 2020 Mar; 32(2):277-281. PubMed ID: 31608815
    [No Abstract]   [Full Text] [Related]  

  • 30. Clostridium perfringens type-D enterotoxaemia in cattle: the diagnostic significance of intestinal epsilon toxin.
    Jones AL; Dagleish MP; Caldow GL
    Vet Rec; 2015 Oct; 177(15):390. PubMed ID: 26428898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of Clostridium perfringens epsilon toxin by ELISA.
    Naylor RD; Martin PK; Sharpe RT
    Res Vet Sci; 1987 Mar; 42(2):255-6. PubMed ID: 2884704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of labeled Clostridium perfringens epsilon toxin in mice.
    Nagahama M; Sakurai J
    Toxicon; 1991; 29(2):211-7. PubMed ID: 2048139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ataxia/paresis syndrome of sheep in West Africa associated with bilateral multifocal cerebrospinal poliomalacia.
    Bonniwell MA; Barlow RM
    Vet Rec; 1985 Jan; 116(4):94-7. PubMed ID: 3976153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Animal models to study the pathogenesis of human and animal Clostridium perfringens infections.
    Uzal FA; McClane BA; Cheung JK; Theoret J; Garcia JP; Moore RJ; Rood JI
    Vet Microbiol; 2015 Aug; 179(1-2):23-33. PubMed ID: 25770894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insights into Clostridium perfringens epsilon toxin activation and action on the brain during enterotoxemia.
    Freedman JC; McClane BA; Uzal FA
    Anaerobe; 2016 Oct; 41():27-31. PubMed ID: 27321761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epsilon toxin: a fascinating pore-forming toxin.
    Popoff MR
    FEBS J; 2011 Dec; 278(23):4602-15. PubMed ID: 21535407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and application of an oral challenge mouse model for studying Clostridium perfringens type D infection.
    Fernandez-Miyakawa ME; Sayeed S; Fisher DJ; Poon R; Adams V; Rood JI; McClane BA; Saputo J; Uzal FA
    Infect Immun; 2007 Sep; 75(9):4282-8. PubMed ID: 17562765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of a Clostridium perfringens type D epsilon toxin producer via dot-blot test.
    Gonçalves LA; Lobato ZI; Silva RO; Salvarani FM; Pires PS; Assis RA; Lobato FC
    Arch Microbiol; 2009 Nov; 191(11):847-51. PubMed ID: 19779698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridium perfringens epsilon toxin inhibits the gastrointestinal transit in mice.
    Losada-Eaton DM; Fernandez-Miyakawa ME
    Res Vet Sci; 2010 Dec; 89(3):404-8. PubMed ID: 20434186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clostridium perfringens epsilon toxin causes excessive release of glutamate in the mouse hippocampus.
    Miyamoto O; Sumitani K; Nakamura T; Yamagami S; Miyata S; Itano T; Negi T; Okabe A
    FEMS Microbiol Lett; 2000 Aug; 189(1):109-13. PubMed ID: 10913875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.